KEY FACTS

• UK based private company founded in 2013, with an intellectual property portfolio comprising granted patents in multiple countries.
• Pipeline of 3 medical device technologies under pre-clinical and clinical development
• Awarded 4 highly competitive British Government grants to date, recognising the potential impact of our innovative technologies.
• Newtec vascular shareholders include investors from the following funds and investor networks: